MreB filaments align along greatest principal membrane curvature to orient cell wall synthesis

  1. Saman Hussain
  2. Carl N Wivagg
  3. Piotr Szwedziak
  4. Felix Wong
  5. Kaitlin Schaefer
  6. Thierry Izoré
  7. Lars D Renner
  8. Matthew J Holmes
  9. Yingjie Sun
  10. Alexandre W Bisson-Filho
  11. Suzanne Walker
  12. Ariel Amir
  13. Jan Löwe
  14. Ethan C Garner  Is a corresponding author
  1. Harvard University, United States
  2. MRC Laboratory of Molecular Biology, United Kingdom
  3. Harvard John A. Paulson School of Engineering and Applied Sciences, United States
  4. Leibniz Institute of Polymer Research, Germany

Abstract

MreB is essential for rod shape in many bacteria. Membrane-associated MreB filaments move around the rod circumference, helping to insert cell wall in the radial direction to reinforce rod shape. To understand how oriented MreB motion arises, we altered the shape of Bacillus subtilis. MreB motion is isotropic in round cells, and orientation is restored when rod shape is externally imposed. Stationary filaments orient within protoplasts, and purified MreB tubulates liposomes in vitro, orienting within tubes. Together, this demonstrates MreB orients along the greatest principal membrane curvature, a conclusion supported with biophysical modeling. We observed that spherical cells regenerate into rods in a local, self-reinforcing manner: rapidly propagating rods emerge from small bulges, exhibiting oriented MreB motion. We propose that the coupling of MreB filament alignment to shape-reinforcing peptidoglycan synthesis creates a locally-acting, self-organizing mechanism allowing the rapid establishment and stable maintenance of emergent rod shape.

Article and author information

Author details

  1. Saman Hussain

    Department of Molecular and Cellular Biology, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Carl N Wivagg

    Department of Molecular and Cellular Biology, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Piotr Szwedziak

    MRC Laboratory of Molecular Biology, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5766-0873
  4. Felix Wong

    Harvard John A. Paulson School of Engineering and Applied Sciences, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2309-8835
  5. Kaitlin Schaefer

    Department of Microbiology and Immunology, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Thierry Izoré

    MRC Laboratory of Molecular Biology, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Lars D Renner

    Leibniz Institute of Polymer Research, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Matthew J Holmes

    Department of Molecular and Cellular Biology, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Yingjie Sun

    Department of Molecular and Cellular Biology, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Alexandre W Bisson-Filho

    Department of Molecular and Cellular Biology, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Suzanne Walker

    Department of Chemistry and Chemical Biology, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Ariel Amir

    Harvard John A. Paulson School of Engineering and Applied Sciences, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2611-0139
  13. Jan Löwe

    MRC Laboratory of Molecular Biology, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5218-6615
  14. Ethan C Garner

    Department of Molecular and Cellular Biology, Harvard University, Cambridge, United States
    For correspondence
    egarner@g.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0141-3555

Funding

National Institutes of Health (DP2AI117923-01)

  • Ethan C Garner

Volkswagen Foundation

  • Lars D Renner
  • Ariel Amir
  • Ethan C Garner

Wellcome (095514/Z/11/Z)

  • Jan Löwe

National Science Foundation (GFRP)

  • Felix Wong

Medical Research Council (U105184326)

  • Jan Löwe

Howard Hughes Medical Institute (International Student Research Fellow)

  • Saman Hussain

National Institutes of Health (R01 GM076710)

  • Suzanne Walker

Searle Scholar Fellowship

  • Ethan C Garner

Alfred P. Sloan Foundation

  • Ariel Amir

Smith Family Award

  • Ethan C Garner

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Tâm Mignot, Aix Marseille University-CNRS UMR7283, France

Version history

  1. Received: October 3, 2017
  2. Accepted: February 21, 2018
  3. Accepted Manuscript published: February 22, 2018 (version 1)
  4. Accepted Manuscript updated: February 26, 2018 (version 2)
  5. Version of Record published: March 15, 2018 (version 3)

Copyright

© 2018, Hussain et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 7,094
    views
  • 1,036
    downloads
  • 175
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Saman Hussain
  2. Carl N Wivagg
  3. Piotr Szwedziak
  4. Felix Wong
  5. Kaitlin Schaefer
  6. Thierry Izoré
  7. Lars D Renner
  8. Matthew J Holmes
  9. Yingjie Sun
  10. Alexandre W Bisson-Filho
  11. Suzanne Walker
  12. Ariel Amir
  13. Jan Löwe
  14. Ethan C Garner
(2018)
MreB filaments align along greatest principal membrane curvature to orient cell wall synthesis
eLife 7:e32471.
https://doi.org/10.7554/eLife.32471

Share this article

https://doi.org/10.7554/eLife.32471

Further reading

    1. Epidemiology and Global Health
    2. Microbiology and Infectious Disease
    Patrick E Brown, Sze Hang Fu ... Ab-C Study Collaborators
    Research Article Updated

    Background:

    Few national-level studies have evaluated the impact of ‘hybrid’ immunity (vaccination coupled with recovery from infection) from the Omicron variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

    Methods:

    From May 2020 to December 2022, we conducted serial assessments (each of ~4000–9000 adults) examining SARS-CoV-2 antibodies within a mostly representative Canadian cohort drawn from a national online polling platform. Adults, most of whom were vaccinated, reported viral test-confirmed infections and mailed self-collected dried blood spots (DBSs) to a central lab. Samples underwent highly sensitive and specific antibody assays to spike and nucleocapsid protein antigens, the latter triggered only by infection. We estimated cumulative SARS-CoV-2 incidence prior to the Omicron period and during the BA.1/1.1 and BA.2/5 waves. We assessed changes in antibody levels and in age-specific active immunity levels.

    Results:

    Spike levels were higher in infected than in uninfected adults, regardless of vaccination doses. Among adults vaccinated at least thrice and infected more than 6 months earlier, spike levels fell notably and continuously for the 9-month post-vaccination. In contrast, among adults infected within 6 months, spike levels declined gradually. Declines were similar by sex, age group, and ethnicity. Recent vaccination attenuated declines in spike levels from older infections. In a convenience sample, spike antibody and cellular responses were correlated. Near the end of 2022, about 35% of adults above age 60 had their last vaccine dose more than 6 months ago, and about 25% remained uninfected. The cumulative incidence of SARS-CoV-2 infection rose from 13% (95% confidence interval 11–14%) before omicron to 78% (76–80%) by December 2022, equating to 25 million infected adults cumulatively. However, the coronavirus disease 2019 (COVID-19) weekly death rate during the BA.2/5 waves was less than half of that during the BA.1/1.1 wave, implying a protective role for hybrid immunity.

    Conclusions:

    Strategies to maintain population-level hybrid immunity require up-to-date vaccination coverage, including among those recovering from infection. Population-based, self-collected DBSs are a practicable biological surveillance platform.

    Funding:

    Funding was provided by the COVID-19 Immunity Task Force, Canadian Institutes of Health Research, Pfizer Global Medical Grants, and St. Michael’s Hospital Foundation. PJ and ACG are funded by the Canada Research Chairs Program.

    1. Microbiology and Infectious Disease
    Alejandro Prieto, Luïsa Miró ... Antonio Juarez
    Research Article

    Antimicrobial resistance (AMR) poses a significant threat to human health. Although vaccines have been developed to combat AMR, it has proven challenging to associate specific vaccine antigens with AMR. Bacterial plasmids play a crucial role in the transmission of AMR. Our recent research has identified a group of bacterial plasmids (specifically, IncHI plasmids) that encode large molecular mass proteins containing bacterial immunoglobulin-like domains. These proteins are found on the external surface of the bacterial cells, such as in the flagella or conjugative pili. In this study, we show that these proteins are antigenic and can protect mice from infection caused by an AMR Salmonella strain harboring one of these plasmids. Furthermore, we successfully generated nanobodies targeting these proteins, that were shown to interfere with the conjugative transfer of IncHI plasmids. Considering that these proteins are also encoded in other groups of plasmids, such as IncA/C and IncP2, targeting them could be a valuable strategy in combating AMR infections caused by bacteria harboring different groups of AMR plasmids. Since the selected antigens are directly linked to AMR itself, the protective effect extends beyond specific microorganisms to include all those carrying the corresponding resistance plasmids.